Sign in

CIK 0001080014

  • Large accelerated filer

Innoviva, Inc.

Sign in to watch
Ticker
INVA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943265960
Phone
+1 650-238-9600
Business address
1350 OLD BAYSHORE HIGHWAY, SUITE 400, BURLINGAME, CA, 94010
Former names
THERAVANCE INC, ADVANCED MEDICINE INC
  1. 4 Shares withheld for taxes Chief Accounting Officer gave up 536 shares (to pay taxes)
  2. 4 Open-market sale Sr. VP & Chief Comm. Officer sold 8,000 shares at $14.11 ($112,840)
  3. 4 Open-market sale Sr. VP & Chief Scientific Off. sold 8,504 shares at $14.12 ($120,080)
  4. 3 Insider Initial Statement of Ownership
  5. 3 Insider Initial Statement of Ownership
  6. 4 Open-market sale SVP and CFO sold 5,808 shares at $14.40 ($83,623)
  7. 4 Open-market sale Sr. VP & Chief Comm. Officer sold 8,000 shares at $14.40 ($115,202)
  8. 4 Shares withheld for taxes Sr. VP & Chief Scientific Off. gave up 3,089 shares (to pay taxes)
  9. 4 Grant or award Director acquired 14,249 shares (grant or award)
  10. 4 Grant or award Director acquired 14,249 shares (grant or award)
  11. 4 Grant or award Director acquired 14,249 shares (grant or award)
  12. 4 Grant or award Director acquired 14,249 shares (grant or award)
  13. 4 Grant or award Director acquired 14,249 shares (grant or award)
  14. 4 Grant or award Interim PEO, SVP and CFO acquired 93,056 shares (grant or award)
  15. 4 Grant or award Sr. VP & Chief Comm. Officer acquired 74,444 shares (grant or award)
  16. 4 Grant or award Sr. VP & Chief Scientific Off. acquired 74,444 shares (grant or award)
  17. 4 Open-market sale Interim PEO, SVP and CFO sold 5,378 shares at $16.52 ($88,825)
  18. 4 Open-market sale Sr. VP & Chief Scientific Off. sold 9,890 shares at $16.60 ($164,148)
  19. 4 Open-market sale Sr. VP & Chief Comm. Officer sold 8,000 shares at $16.51 ($132,100)
  20. 4 Grant or award Director acquired 10,517 shares (grant or award)

Page 9 of 39 · 776 filings